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Background: Impaired diastolic function may increase intracardiac filling pressures, contributing to acute decompensation of heart failure (HF) 
that is the target for vasoactive therapies. However, the impact of such therapies on improving diastolic dysfunction is not well described, particularly 
in those with underlying systolic impairment.
Methods: We prospectively examined 73 consecutive patients with acute decompensated systolic HF admitted to the heart failure intensive care 
unit who underwent simultaneous echocardiographic and hemodynamic evaluation on admission and after 48 hours of intensive vasoactive therapy 
with the goal to optimize hemodynamic derangements.
Results: In our study cohort (mean age 56±12 years, EF 27±9%) with predominantly high filling pressures (pulmonary capillary wedge pressure 
[PCWP] 21±7 mmHg) and low output state (cardiac index [CI] 2.1±0.6 L/min/m 2), the majority of patients (82%) demonstrated advanced 
(stage III) diastolic dysfunction. Among those with advanced diastolic dysfunction, 78% demonstrated no changes in diastolic staging or other 
echocardiographic parameters despite overall improved cardiac indices with vasoactive therapy (p =0.002). In contrast, 13% of the whole cohort 
showed improvement in diastolic staging that was concordant with favorable changes in hemodynamics (CI, p=0.03) as well as echocardiographic 
parameters including reduction in left ventricular indexed volumes (p <0.03), improvement with right ventricular mid peak systolic strain (p=0.04) 
and Tei index (p=0.04).
Conclusions: The majority of patients in our cohort with decompensated systolic HF demonstrated advanced diastolic dysfunction, which did 
not change with intensive vasoactive therapy regardless of improvement in hemodynamic measurements. This discordance may reflect the lack of 
intrinsic myocardial reserve in the setting of advanced systolic heart failure.
